Pharmaceutical company Insmed is taking Wall Street by surprise today, falling to $66.29 and marking a -7.0% change compared ...

Wolfspeed (NYSE: WOLF) has announced a significant leadership transition, with Gregg Lowe departing from his roles as President and CEO, as well as a member of the board of directors. The current ...

Boston Scientific expects the acquisition to have a positive impact on its future earnings. Specifically, the company ...

Cytokinetics sank -8.2% this morning, compared to the S&P 500's day change of -1.0%. Today's losers may turn out to be ...

AT&T shares rose 1.9% this morning to a price of $22.68. The stock is still trading within range of its average target price ...

4 analysts are following Grifols and have set target prices ranging from $8.93 to $11.8 per share. On average, they have given the company a rating of buy. At today's prices, GRFS is trading -14.06% ...

Thermo Fisher Scientific stock is trading -21.47% below its average target price of $653.35 after dropping -3.7% during today ...

The cash flow from operating activities also experienced a decrease, with cash generated from operating activities declining ...

Gladstone Commercial Corporation is a real estate investment trust ("REIT") focused on acquiring, owning, and operating net ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) has released positive new clinical data from the ongoing phase 1 trial of Nexiguran Ziclumeran (Nex-Z), also known as NTLA-2001, in patients with ...

The offering of the notes is contingent on the closing of an amendment and restatement of the company's existing credit agreement governing the existing term a loan facility and revolving credit ...

Following Mr. Brubaker’s departure, Michael LiCalsi, the company’s General Counsel and Secretary, will assume certain ...